NCKAP1 and cancer: Specifically, high NCKAP1 expression correlated with poor survival in adrenocortical carcinoma (ACC, p = 0.061), cervical squamous cell carcinoma (CESC, p = 0.020), and LIHC (p = 0.037) patients, indicating that NCKAP1 may serve as an adverse prognostic factor in those cancer types.